NeoGenomics Inc. (NASDAQ: NEO) started the day on June 29, 2020, with a price increase of 6.93% at $29.16. During the day, the stock rose to $29.21 and sunk to $27.28 before settling in for the price of $27.27 at the close. Taking a more long-term approach, NEO posted a 52-week range of $18.52-$34.97.
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 36.20%. Meanwhile, its Annual Earning per share during the time was 30.80%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 16.20%. This publicly-traded company’s shares outstanding now amounts to $104.48 million, simultaneously with a float of $101.60 million. The organization now has a market capitalization sitting at $3.46 billion. At the time of writing, stock’s 50-day Moving Average stood at $27.83, while the 200-day Moving Average is $26.73.
If we measure the efficiency of the company that is accounted for 1700 employees. It has generated 240,488 per worker during the last fiscal year. Meanwhile, its income per employee was 4,709. The stock had 4.75 Receivables turnover and 0.67 Total Asset turnover. For the Profitability, stocks gross margin was +43.05, operating margin was +3.96 and Pretax Margin of +0.89.
NeoGenomics Inc. (NEO) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Diagnostics & Research Industry. NeoGenomics Inc.’s current insider ownership accounts for 2.90%, in contrast to 85.90% institutional ownership. According to the most recent insider trade that took place on Mar 04, this organization’s President, Clinical Services sold 98,093 shares at the rate of 30.86, making the entire transaction reach 3,027,150 in total value, affecting insider ownership by 151,640. Preceding that transaction, on Mar 02, Company’s Director sold 297,300 for 28.77, making the whole transaction’s value amount to 8,554,252. This particular insider is now the holder of 30,476 in total.
NeoGenomics Inc. (NEO) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 3/30/2020, the organization reported -$0.02 earnings per share (EPS) for the three months, lower than the consensus estimate (set at $0.02) by -$0.04. This company achieved a net margin of +1.96 while generating a return on equity of 1.93. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.02 per share during the current fiscal year.
NeoGenomics Inc.’s EPS increase for this current 12-month fiscal period is 16.20% and is forecasted to reach 0.36 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 12.00% through the next 5 years, which can be compared against the 30.80% growth it accomplished over the previous five years trading on the market.
NeoGenomics Inc. (NASDAQ: NEO) Trading Performance Indicators
Let’s observe the current performance indicators for NeoGenomics Inc. (NEO). It’s Quick Ratio in the last reported quarter now stands at 2.90. The Stock has managed to achieve an average true range (ATR) of 1.41. Alongside those numbers, its PE Ratio stands at $911.25, and its Beta score is 0.75. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 8.26.
In the same vein, NEO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.03, a figure that is expected to reach -0.10 in the next quarter, and analysts are predicting that it will be 0.36 at the market close of one year from today.
Technical Analysis of NeoGenomics Inc. (NEO)
If we take a close look at the recent performances of NeoGenomics Inc. (NASDAQ: NEO), its last 5-days Average volume was 1.19 million that shows progress from its year to date volume of 1.03 million. During the previous 9 days, stock’s Stochastic %D was recorded 63.82% While, its Average True Range was 1.49.
Raw Stochastic average of NeoGenomics Inc. (NEO) in the period of the previous 100 days is set at 68.48%, which indicates a major fall in contrast to 94.32% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 66.15% that was lower than 87.57% volatility it exhibited in the past 100-days period.